Australian Doctor 
 News

Diabetic drug cuts kidney failure risk by a third

Canagliflozin also reduced the risk of major cardiovascular events by 20%
1
15 April 2019
Save
Kidneys

A glucose-lowering medication has been found to have striking benefits in reducing the risk of kidney failure in patients with type 2 diabetes, an Australian-led study has found.

And research leaders believe the renal benefits may be common to other drugs in the SGLT-2 inhibitor class.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .